(5023) Ds Zenition 70
Payments companies reported to CMS as associated with (5023) Ds Zenition 70. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (5023) Ds Zenition 70, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (5023) Ds Zenition 70
These are the largest totals companies reported as associated with (5023) Ds Zenition 70. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ali Meslemani | Livonia, MI | Surgery | $493.48 |
| Ali Harb | Detroit, MI | Vascular & Interventional Radiology | $310.27 |
| Ahmad Aslam | Tomball, TX | Cardiovascular Disease | $241.66 |
| Satyaki Banerjee | Albuquerque, NM | Nephrology (Internal Medicine) | $94.60 |
| Nathan Itoga | Honolulu, HI | Vascular Surgery | $68.56 |
| Brant Ullery | Wilsonville, OR | Vascular Surgery | $67.20 |
| Gaurav Aggarwala | Huntsville, TX | Cardiovascular Disease | $58.78 |
| Paul Gagne | Darien, CT | Vascular Surgery | $40.62 |
| Nikhil Nalluri | Desoto, TX | Interventional Cardiology | $34.67 |
| Deepak Asti | Desoto, TX | Interventional Cardiology | $34.67 |
Prescribed (5023) Ds Zenition 70?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.